Background: Evidence and practice recommendations on the use of transanal total mesorectal excision (TaTME) for rectal cancer are conflicting.
Objective: We aimed to summarize best evidence and develop a rapid guideline using transparent, trustworthy, and standardized methodology.
Methods: We developed a rapid guideline in accordance with GRADE, G-I-N, and AGREE II standards.